We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $566M
1-Year Est. Return 197.74%
This Fund
S&P 500
This Quarter Est. Return
+2.52%
1 Year Est. Return
+197.74%
3 Year Est. Return
+371.51%
5 Year Est. Return
+473.27%
10 Year Est. Return
AUM
$207M
AUM Growth
-$43.5M
Cap. Flow
+$7.49M
Cap. Flow %
3.62%
Top 10 Hldgs %
40.41%
Holding
113
New
16
Increased
29
Reduced
21
Closed
26

Sector Composition

Rank Sector Weight
1 Healthcare 35.36%
2 Miscellaneous 25.88%
3 Technology 18.94%
4 Communication Services 8.24%
5 Consumer Discretionary 5.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GDXJ icon
51
VanEck Junior Gold Miners ETF
GDXJ
$9.19B
$919K 0.44%
21,500
+2,500
+13% +$121K
SPOT icon
52
Spotify
SPOT
$111B
$895K 0.43%
2,000
-1,165
-37% -$499K
PYPL icon
53
PayPal
PYPL
$45.4B
$854K 0.41%
10,000
DE icon
54
Deere & Co
DE
$183B
$847K 0.41%
2,000
-2,500
-56% -$1.05M
INTC icon
55
Intel
INTC
$578B
$827K 0.4%
41,250
-3,750
-8% -$84.5K
OI icon
56
O-I Glass
OI
$962M
$805K 0.39%
74,250
CSCO icon
57
CALL
Cisco
CSCO
$439B
$740K 0.36%
+12,500
New +$714K
SNY icon
58
Sanofi
SNY
$103B
$699K 0.34%
14,500
+3,500
+32% +$178K
VRDN icon
59
Viridian Therapeutics
VRDN
$2.5B
$570K 0.28%
29,750
+15,250
+105% +$332K
LRCX icon
60
Lam Research
LRCX
$336B
$542K 0.26%
7,500
+2,500
+50% +$190K
TDOC icon
61
Teladoc Health
TDOC
$1.17B
$477K 0.23%
52,500
FLUT icon
62
Flutter Entertainment
FLUT
$16.7B
$388K 0.19%
1,500
-1,000
-40% -$252K
TEVA icon
63
CALL
Teva Pharmaceutical Industries Limited
TEVA
$46.1B
$331K 0.16%
15,000
-18,500
-55% -$337K
NOK icon
64
Nokia
NOK
$59B
$222K 0.11%
50,000
OI icon
65
CALL
O-I Glass
OI
$962M
$130K 0.06%
+12,000
New +$146K
IONS icon
66
CALL
Ionis Pharmaceuticals
IONS
$7.7B
$69.9K 0.03%
2,000
-2,000
-50% -$74.8K
WOLF icon
67
Wolfspeed
WOLF
$1.28B
$66.6K 0.03%
10,000
-10,600
-51% -$108K
LCTX icon
68
Lineage Cell Therapeutics
LCTX
$268M
$54.1K 0.03%
107,751
EQ icon
69
Equillium
EQ
$120M
$47.1K 0.02%
62,947
+29,985
+91% +$24.8K
TBHC
70
DELISTED
The Brand House Collective
TBHC
$39.1K 0.02%
24,165
-1,250
-5% -$2.26K
OVID icon
71
Ovid Therapeutics
OVID
$537M
$11K 0.01%
11,750
-3,000
-20% -$3.36K
AAPL icon
72
PUT
Apple
AAPL
$4.87T
-5,000
Closed -$1.17M
ALT icon
73
CALL
Altimmune
ALT
$646M
-57,000
Closed -$350K
ALT icon
74
Altimmune
ALT
$646M
-37,868
Closed -$233K
AMZN icon
75
CALL
Amazon
AMZN
$2.72T
-3,000
Closed -$559K

Similar funds

DCF Advisers's Q4 2024 Portfolio in Review

As of Q4 2024, DCF Advisers held 113 positions worth $207M, down 17% from $250M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

DCF Advisers deployed $7.49M of net new capital in Q4 2024, opening 16 new positions and adding to 29 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 27% a quarter earlier, followed by Miscellaneous and Technology.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $2.16M trimmed.

  • DCF Advisers added most to Advanced Micro Devices in Q4 2024, an estimated $1.73M increase.
  • DCF Advisers's biggest Q4 2024 reduction was Alphabet (Google) Class C, cutting an estimated $2.16M.
  • DCF Advisers fully exited Energy Transfer Partners in Q4 2024, selling an estimated $4.96M.
  • DCF Advisers's ten largest holdings make up 40% of its $207M portfolio in Q4 2024.
  • DCF Advisers opened 16 new positions and closed 26 in Q4 2024.
  • DCF Advisers's portfolio value fell 17% quarter-over-quarter to $207M.

Based on DCF Advisers's 13F filing for Q4 2024, filed 11 Feb 2025.